Thermo Fisher Scientific announced this week the formation of a scientific advisory board intended to formalize its interaction with leading research centers around the world.
The newly formed board includes Thermo Fisher board member and Massachusetts Institute of Technology biology professor Tyler Jacks; Ronald Davis of Stanford University's department of biochemistry; Steven Gygi of Harvard Medical School's department of cell biology; William Hahn of Dana-Farber Cancer Institute's department of medical oncology; and David Hillyard of the University of Utah's department of pathology.
Pierre Meulien was appointed this week president and CEO of Genome Canada.
Meulien will be stepping down from his role as chief scientific officer of Genome BC to take the new position. Previously he worked as senior vice president of R&D and director of research at Aventis Pasteur.